SEC suspended AVNE on March 5, 2013. However, before that time, iequity had bundled the IP and transferred it to AVNE via AV Labs for 10m shares of AVNE. This transaction gave iequity controlling shareholder status alongside two AVNE principals.

Iequity has transferred IP to Medical Greens.